1,1'-ethylidene bis(tryptophan) has been researched along with Symptom Cluster in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barth, H; Berg, PA; Klein, R | 1 |
| Kasahara, T; Miura, Y; Shioiri-Nakano, K; Suda, T; Tsunoda, J; Yamaguchi, Y | 1 |
| Ames, MM; Foote, CS; Gleich, GJ; Hedberg, CW; Lin, F; Loegering, DA; Mayeno, AN | 1 |
3 other study(ies) available for 1,1'-ethylidene bis(tryptophan) and Symptom Cluster
| Article | Year |
|---|---|
L-tryptophan contaminant 'peak E' induces the release of IL-5 and IL-10 by peripheral blood mononuclear cells from patients with functional somatic syndromes.
Topics: Adult; Case-Control Studies; Cytokines; Drug Contamination; Eosinophilia-Myalgia Syndrome; Female; Fibromyalgia; Humans; In Vitro Techniques; Interleukin-10; Interleukin-5; Leukocytes, Mononuclear; Male; Middle Aged; Risk Factors; Syndrome; Th2 Cells; Tryptophan | 2001 |
Effect of synthesized constituents in the L-tryptophan product on the differentiation of eosinophils and the induction of IL-6: a possible cause of eosinophilia-myalgia syndrome.
Topics: Bone Marrow; Bone Marrow Cells; Carbolines; Cell Differentiation; Edema; Eosinophilia; Eosinophils; Hematopoietic Stem Cells; Humans; Interleukin-1; Interleukin-2; Interleukin-6; Muscular Diseases; Reference Values; Syndrome; Tryptophan | 1991 |
Characterization of "peak E," a novel amino acid associated with eosinophilia-myalgia syndrome.
Topics: Chromatography, High Pressure Liquid; Eosinophilia; Humans; Magnetic Resonance Spectroscopy; Molecular Structure; Muscles; Pain; Spectrometry, Mass, Fast Atom Bombardment; Syndrome; Tryptophan | 1990 |